They also said that while current Alzheimer's drugs lose their effectiveness between three and six months, Dimebon still worked after at least a year.
The drug has to go through more clinical trials and won't be approved for at least two years.
They also said that while current Alzheimer's drugs lose their effectiveness between three and six months, Dimebon still worked after at least a year.
The drug has to go through more clinical trials and won't be approved for at least two years.